1 |
Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Takeshima H, et al. 1989. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature 340: 230-233.
DOI
|
2 |
Ohtsubo K, Marth JD. 2006. Glycosylation in cellular mechanisms of health and disease. Cell 126: 855-867.
DOI
|
3 |
Orestes P, Osuru HP, McIntire WE, Jacus MO, Salajegheh R, Jagodic MM, et al. 2013. Reversal of neuropathic pain in diabetes by targeting glycosylation of CaV3.2 T-type calcium channels. Diabetes 62: 3828-3838.
DOI
|
4 |
Perez-Reyes E. 2003. Molecular physiology of low-voltageactivated T-type calcium channels. Physiol. Rev. 83: 117–161.
DOI
|
5 |
Schwetz TA, Norring SA, Bennett ES. 2010. N-glycans modulate Kv1.5 gating but have no effect on Kv1.4 gating. Biochim. Biophys. Acta 1798: 367-375.
DOI
|
6 |
Scott H, Panin VM. 2014. The role of protein N-glycosylation in neural transmission. Glycobiology 24: 407-417.
DOI
|
7 |
Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, et al. 2004. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119: 19-31.
DOI
|
8 |
Weiss N, Black SA, Bladen C, Chen L, Zamponi GW. 2013. Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation. Pflugers Arch. 465: 1159-1170.
DOI
|
9 |
Bennett ES. 2002. Isoform-specific effects of sialic acid on voltage-dependent Na+ channel gating: functional sialic acids are localized to the S5-S6 loop of domain I. J. Physiol. 538: 675-690.
DOI
|
10 |
Catterall WA. 2011. Voltage-gated calcium channels. Cold Spring Harbor Perspect. Biol. 3: a003947.
DOI
|
11 |
Egenberger B, Polleichtner G, Wischmeyer E, Doring F. 2010. N-linked glycosylation determines cell surface expression of two-pore-domain K+ channel TRESK. Biochem. Biophys. Res. Commun. 391: 1262-1267.
DOI
|
12 |
Eklund EA, Freeze HH. 2006. The congenital disorders of glycosylation: a multifaceted group of syndromes. NeuroRx 3: 254-263.
DOI
|
13 |
Wheeler DG, Groth RD, Ma H, Barrett CF, Owen SF, Safa P, Tsien RW. 2012. CaV1 and CaV2 channels engage distinct modes of Ca2+ signaling to control CREB-dependent gene expression. Cell 149: 1112-1124.
DOI
|
14 |
Fujita T, Utsunomiya I, Ren J, Matsushita Y, Kawai M, Sasaki S, et al. 2006. Glycosylation and cell surface expression of Kv1.2 potassium channel are regulated by determinants in the pore region. Neurochem. Res. 31: 589-596.
DOI
|
15 |
Hall MK, Reutter W, Lindhorst T, Schwalbe RA. 2011. Biochemical engineering of the N-acyl side chain of sialic acids alters the kinetics of a glycosylated potassium channel Kv 3.1. FEBS Lett. 585: 3322-3327.
DOI
|
16 |
Hofmann F, Flockerzi V, Kahl S, Wegener JW. 2014. L-type CaV1.2 calcium channels: from in vitro findings to in vivo function. Physiol. Rev. 94: 303-326.
DOI
|
17 |
Lee JH, Han DP. 2001. Expression of low voltage-activated Ca2+ channels in Xenopus oocytes. J. Microbiol. Biotechnol. 11: 614-618.
|